Global Intranasal Drug & Vaccine Delivery Market by Product (Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler), Dosage (Multi-Dose, Unit-Dose), Application, Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Intranasal Drug & Vaccine Delivery Market by Product (Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler), Dosage (Multi-Dose, Unit-Dose), Application, Distribution Channel - Forecast 2024-2030

Report
188 Pages
March 2024
Region: Global
360iResearch™
ID: 5533387

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Intranasal Drug & Vaccine Delivery Market size was estimated at USD 51.89 billion in 2023, USD 55.88 billion in 2024, and is expected to grow at a CAGR of 8.17% to reach USD 89.93 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intranasal Drug & Vaccine Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intranasal Drug & Vaccine Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intranasal Drug & Vaccine Delivery Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AstraZeneca PLC, Bausch Health Companies Inc., Baxter International, Inc., Becton, Dickinson, and Company, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Marina Biotech, Inc., Merck & Co., Inc., Neurelis Inc., Novartis AG, OptiNose, Inc., Pfizer Inc., Teleflex Incorporated, and Teva Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Intranasal Drug & Vaccine Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Liquid Delivery Device
- Powder Delivery Device
- Pressurized Metered Dose Inhaler
Dosage
- Multi-Dose
- Unit-Dose
Application
- Neurological Disorders
- Pain Management
- Respiratory Disorders
- Vaccination
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Intranasal Drug & Vaccine Delivery Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intranasal Drug & Vaccine Delivery Market?
What are the technology trends and regulatory frameworks in the Intranasal Drug & Vaccine Delivery Market?
What is the market share of the leading vendors in the Intranasal Drug & Vaccine Delivery Market?
Which modes and strategic moves are suitable for entering the Intranasal Drug & Vaccine Delivery Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Intranasal Drug & Vaccine Delivery Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of respiratory and neurological diseases
5.1.1.2. Expansion of supply chain networks and commercialization
5.1.1.3. Rise in number of prescriptions for non-invasive drug delivery routes
5.1.2. Restraints
5.1.2.1. Side effects associated with the use of nasal routes
5.1.3. Opportunities
5.1.3.1. Improving healthcare infrastructure and advanced treatment availability in developing economies
5.1.3.2. Technological advancements related to nasal drug delivery systems
5.1.4. Challenges
5.1.4.1. Development challenges such as requirements of large dose of vaccine and administration difficulties through the nasal route
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Intranasal Drug & Vaccine Delivery Market, by Product

6.1. Introduction
6.2. Liquid Delivery Device
6.3. Powder Delivery Device
6.4. Pressurized Metered Dose Inhaler

7. Intranasal Drug & Vaccine Delivery Market, by Dosage

7.1. Introduction
7.2. Multi-Dose
7.3. Unit-Dose

8. Intranasal Drug & Vaccine Delivery Market, by Application

8.1. Introduction
8.2. Neurological Disorders
8.3. Pain Management
8.4. Respiratory Disorders
8.5. Vaccination

9. Intranasal Drug & Vaccine Delivery Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies

10. Americas Intranasal Drug & Vaccine Delivery Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Intranasal Drug & Vaccine Delivery Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Intranasal Drug & Vaccine Delivery Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. 3M Company
14.1.2. AstraZeneca PLC
14.1.3. Bausch Health Companies Inc.
14.1.4. Baxter International, Inc.
14.1.5. Becton, Dickinson, and Company
14.1.6. GlaxoSmithKline PLC
14.1.7. Johnson & Johnson Services, Inc.
14.1.8. Marina Biotech, Inc.
14.1.9. Merck & Co., Inc.
14.1.10. Neurelis Inc.
14.1.11. Novartis AG
14.1.12. OptiNose, Inc.
14.1.13. Pfizer Inc.
14.1.14. Teleflex Incorporated
14.1.15. Teva Pharmaceutical Industries Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. INTRANASAL DRUG & VACCINE DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTRANASAL DRUG & VACCINE DELIVERY MARKET DYNAMICS
FIGURE 7. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
FIGURE 10. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. INTRANASAL DRUG & VACCINE DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. INTRANASAL DRUG & VACCINE DELIVERY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. INTRANASAL DRUG & VACCINE DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY LIQUID DELIVERY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY POWDER DELIVERY DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRESSURIZED METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 10. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY UNIT-DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 36. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. CANADA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. MEXICO INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 58. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CHINA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. INDIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 62. INDIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. JAPAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. JAPAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. THAILAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. THAILAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. DENMARK INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. DENMARK INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. EGYPT INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. EGYPT INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. FINLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FINLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 131. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ITALY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. NORWAY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. NORWAY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. POLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 147. POLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. POLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. QATAR INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 151. QATAR INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. QATAR INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. TURKEY INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. INTRANASAL DRUG & VACCINE DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. INTRANASAL DRUG & VACCINE DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. INTRANASAL DRUG & VACCINE DELIVERY MARKET LICENSE & PRICING

Companies Mentioned

3M Company
AstraZeneca PLC
Bausch Health Companies Inc.
Baxter International, Inc.
Becton, Dickinson, and Company
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Marina Biotech, Inc.
Merck & Co., Inc.
Neurelis Inc.
Novartis AG
OptiNose, Inc.
Pfizer Inc.
Teleflex Incorporated
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 55.88 Billion
Forecasted Market Value ( USD ) by 2030	$ 89.93 Billion
Compound Annual Growth Rate	8.1%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Intranasal Drug and Vaccine Delivery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Vaccine Delivery Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

Global Vaccine Delivery Devices Market by Nature (Needle Based, Needle-Less), Product Type (Jet Injectors, Microneedles, Syringes) - Forecast 2024-2030

Vaccine Delivery Devices Market Size, Share & Trends Analysis Report By Device, By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination), By Region, And Segment Forecasts, 2023 - 2030

Global Vaccine Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029